𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations in the AXIN1 Gene in Advanced Prostate Cancer

✍ Scribed by George W. Yardy; David C. Bicknell; Jennifer L. Wilding; Sylvia Bartlett; Ying Liu; Bruce Winney; Gareth D.H. Turner; Simon F. Brewster; Walter F. Bodmer


Book ID
113610860
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
701 KB
Volume
56
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Detection of point mutations of the Axin
✍ Li-Hua Jin; Qiu-Jie Shao; Wen Luo; Zhi-Yun Ye; Qing Li; Sheng-Cai Lin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 433 KB πŸ‘ 1 views

## Abstract Axin is a recently identified tumor suppressor that plays an important role in liver and colon cancers. To gain further insights into the structure and function of Axin in controlling cell growth, we analyzed 54 colorectal cancer tissues for mutations in AXIN1 gene. We employed PCR ampl

Mutation of the MXI1 gene in prostate ca
✍ Eagle, Linette R.; Yin, Xiaoying; Brothman, Arthur R.; Williams, Briana J.; Atki πŸ“‚ Article πŸ“… 1995 πŸ› Nature Publishing Group 🌐 English βš– 761 KB
Gene amplifications in advanced-stage hu
✍ Fournier, G. ;Latil, A. ;Amet, Y. ;Abalain, J. H. ;Volant, A. ;Mangin, P. ;Floch πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 570 KB

Gene amplification is a model of proto-oncogene alterations occasionally observed in human tumors. This amplification can, in some cases, have prognostic value (N-myc in neuroblastoma, c-erbB2 and int-2 in breast cancer, etc.). Amplifications of the proto-oncogenes c-myc, c-erbB2 and int-2 have not

PTEN/MMAC1 mutations in prostate cancer
✍ MΓΌller, M; Rink, K; Krause, H; Miller, K πŸ“‚ Article πŸ“… 2000 πŸ› Nature Publishing Group 🌐 English βš– 32 KB
Germline mutations of the MSR1 gene in p
✍ Christiane Maier; Zorica Vesovic; Natascha Bachmann; Kathleen Herkommer; Anja K. πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 1 views

The MSR1 gene at 8p22 has been suggested as a candidate gene for hereditary prostate cancer because germline variants have been found to be associated with the disease. Aside from a single nonsense mutation (R293X) that was found repeatedly at low frequencies in several samples, little evidence has